King & Spalding

Partner

John Shakow focuses on complex regulatory, commercial, investigation and litigation issues related to pharmaceutical government pricing and price reporting. A partner in the FDA and Life Sciences practice and co-chair of the firm's Life Sciences & Healthcare Industry Group, John represents pharmaceutical and biotechnology manufacturers in every facet of government drug payor program compliance and liability mitigation.

Mr. Shakow has over 25 years' experience in helping pharmaceutical and biotechnology clients resolve commercial and organizational challenges while maintaining the integrity of their price-reporting compliance efforts.